GlassScriptPhysician profile
Adnan Zubair
NPI 1962810846
$7,577.73
in general payments reported to CMS, 2019-2025
31 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $125 · 2021: $3,976 · 2022: $514 · 2023: $1,618 · 2024: $347 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336 · Travel and Lodging: $1,053 · Long Term Medical Supply Or Device Loan: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.12 |
| Travel and Lodging | $1,053.48 |
| Long Term Medical Supply Or Device Loan | $245.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,250.16 | 2021-2023 | |
| Eclipse Technology Solutions INC. | $848.65 | 2023-2024 | |
| Stryker Corporation | $701.04 | 2019-2025 | Augment Injectable, Sonicpin |
| Liberty Surgical INC. | $559.70 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $350.08 | 2022-2025 | Nuzyra |
| Exactech, INC. | $333.58 | 2021 | |
| Integra Lifesciences Corporation | $292.83 | 2021-2025 | Micromatrix, Integra, Primatrix |
| Organogenesis INC. | $240.69 | 2021-2023 | Puraply |
| Depuy Synthes Sales INC. | $131.11 | 2019-2023 | N/A, Speed |
| Treace Medical Concepts, INC. | $124.56 | 2024 | |
| Grt US Holding, INC. | $104.24 | 2021-2022 | |
| Kerecis Limited | $90.03 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Convatec INC. | $81.84 | 2023-2024 | |
| Bioventus LLC | $75.84 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $45.40 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $38.47 | 2025 | Celleraterx |
| Smith+Nephew, INC. | $34.21 | 2024-2025 | Stravix, Grafix Pl |
| Averitas Pharma INC. | $33.95 | 2023 | Qutenza |
| Zimmer Biomet Holdings, INC. | $27.89 | 2021 | |
| Solventum Corporation | $24.49 | 2025 | Activ.A.C. |
| Dynasplint Systems INC. | $24.30 | 2025 | Dynasplint |
| Surgenex LLC | $20.22 | 2025 | Renograft, Pellograft, Surmatrix |
| Reprise Biomedical, INC. | $20.00 | 2025 | Miro3d |
| Biotissue Holdings INC. | $19.36 | 2022 | |
| Paragon 28, INC. | $17.48 | 2024 | Mtp |
| Amgen INC. | $16.77 | 2024 | Krystexxa |
| Globus Medical, INC. | $15.70 | 2025 | Senza |
| Kci USA, INC. | $15.12 | 2021 | |
| Horizon Therapeutics Plc | $13.60 | 2020 | |
| Journey Medical Corporation | $13.45 | 2020 | |
| Osteomed LLC | $12.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adnan Zubair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.